Skip to main content

Want a detailed portfolio tracker?

Jyong Biotech (MENS) P/E (2025 - 2026)

Jyong Biotech (MENS) P/E from Jun 17, 2025 to Jul 21, 2026. The TTM Jyong Biotech (MENS) P/E is -42.00. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Jyong Biotech (MENS)

YearP/EChange
2026-42.00-34.68%
2025-64.31N/A

Comparison Jyong Biotech (MENS) P/E with competitors

Jyong Biotech (MENS) P/E is -42.00.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.00%
NBYStablecoin Development Corp0.00-100.01%
ENLVEnlivex Ltd0.07-100.18%
FGENFibroGen Inc0.24-100.57%
CHRSCoherus Biosciences Inc0.85-102.02%
FBIOFortress Biotech Inc0.95-102.26%
ORMPOramed Pharmaceuticals Inc1.50-103.58%
AGENAgenus Inc3.01-107.17%
INVAInnoviva Inc3.15-107.51%
VXRTVaxart Inc3.55-108.45%
CRMDCorMedix Inc3.63-108.64%
CVACCureVac N.V.4.45-110.58%
GLPGGalapagos NV4.86-111.57%
SRPTSarepta Therapeutics Inc4.88-111.62%
ABEOAbeona Therapeutics Inc5.39-112.83%
ABUSArbutus Biopharma Corp5.60-113.32%
ZVRAZevra Therapeutics Inc5.89-114.02%
SPROSpero Therapeutics Inc6.23-114.83%
CGENCompugen Ltd6.31-115.03%
RIGLRigel Pharmaceuticals6.87-116.36%
SLXNSilexion Therapeutics Corp7.30-117.37%
OMEROmeros Corporation9.26-122.04%
AUPHAurinia Pharmaceuticals Inc9.58-122.82%
PLXProtalix BioTherapeutics Inc10.89-125.93%
ACADAcadia Pharmaceuticals Inc11.73-127.92%
TBPHTheravance Biopharma Inc12.26-129.19%
ADMAAdma Biologics Inc12.42-129.56%
HRMYHarmony Biosciences Holdings Inc13.82-132.90%
SABSSAB Biotherapeutics Inc14.14-133.65%
NAGENiagen Bioscience Inc14.82-135.28%
INCYIncyte Corp15.82-137.67%
REGNRegeneron Pharmaceuticals Inc15.86-137.75%
PBYIPuma Biotechnology Inc17.32-141.22%
CPRXCatalyst Pharmaceuticals Inc17.44-141.52%
EXELExelixis Inc17.54-141.75%
TGTXTG Therapeutics Inc18.97-145.15%
MDXGMimedx Group Inc20.55-148.93%
XOMAXOMA Royalty Corp22.87-154.46%
ARGXArgen X SE24.30-157.85%
CTMXCytomX Therapeutics Inc24.82-159.09%
XOMAOXOMA Royalty Corp25.34-160.34%
HALOHalozyme Therapeutics Inc25.62-161.00%
XOMAPXOMA Royalty Corp25.67-161.11%
VRTXVertex Pharmaceuticals Inc27.99-166.65%
RPRXRoyalty Pharma plc - Class A28.69-168.30%
SLNOSoleno Therapeutics Inc29.02-169.08%
ASNDAscendis Pharma A/S30.09-171.63%
LGNDLigand Pharmaceuticals Inc - Class B37.91-190.26%
APLSApellis Pharmaceuticals Inc39.02-192.90%
BMRNBiomarin Pharmaceutical Inc42.21-200.50%
KRYSKrystal Biotech Inc45.34-207.95%
ONCBeiGene Ltd69.54-265.56%
PHARPharming Group N.V.75.03-278.62%
TECHBio-Techne Corp101.96-342.74%
VCELVericel Corp109.92-361.70%
ALNYAlnylam Pharmaceuticals Inc117.96-380.85%
GMABGenmab140.29-434.00%
TLXTelix Pharmaceuticals Ltd162.15-486.05%
CORTCorcept Therapeutics Inc212.86-606.77%